Serum leptin and ghrelin in chronic hepatitis C patients with steatosis

被引:0
|
作者
Christos Pavlidis [1 ]
Georgios I Panoutsopoulos [2 ]
Dina Tiniakos [3 ]
Sotirios Koutsounas [4 ]
John Vlachogiannakos [1 ]
Irini Zouboulis-Vafiadis [1 ]
机构
[1] First Department of Propaedeutic Medicine“LAIKO”General Hospital
[2] Department of Nursing,University of Peloponnese,Orthias Artemidos and Plateon,Sparta
[3] Laboratory of Histology and Embryology,Medical School,National and Kapodistrian University of Athens
[4] Reference Center for Viral Hepatitis
关键词
Hepatitis C virus; Steatosis; Leptin; Ghrelin; Sustained virological response;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍]; R512.63 [];
学科分类号
1002 ; 100201 ; 100401 ;
摘要
AIM:To determine the associations between leptin and ghrelin concentrations and sustained virological response(SVR)in chronic hepatitis C patients with ste-atosis.METHODS:We retrospectively assessed 56 patients infected with hepatitis C virus(HCV)genotype-1 and 40 with HCV genotype-3.Patients with decompensated cirrhosis,and those with other causes of chronic liver disease,were excluded.Serum HCV-RNA concentra-tions were measured before the initiation of treatment;at weeks 12(for genotype 1 patients),24 and 48 during treatment;and 24 wk after the end of treatment.Genotype was determined using INNO-LIPA HCV as-says,and serum leptin and ghrelin concentrations were measured using enzyme-linked immunosorbent assay.Biopsy specimens were scored according to the Ishak system and steatosis was graded as mild,moderate,or severe,according to the Brunt classif ication.RESULTS:Overall,SVR was positively related to the presence of genotype-3,to biopsy-determined lower histological stage of liver disease,and lower grade of steatosis.Patients ≥ 40 years old tended to be less responsive to therapy.In genotype-1 infected pa-tients,SVR was associated with a lower grade of liver steatosis,milder fibrosis,and an absence of insulin resistance.Genotype-1 infected patients who did not achieve SVR had significantly higher leptin concen-trations at baseline,with significant increases as the severity of steatosis worsened,whereas those who achieved SVR had higher ghrelin concentrations.In genotype-3 infected patients,SVR was associated only with fibrosis stage and lower homeostasis model as-sessment insulin resistance at baseline,but not with the degree of steatosis or leptin concentrations.Geno-type-3 infected patients who achieved SVR showed signif icant decreases in ghrelin concentration at end of treatment.Baseline ghrelin concentrations were elevat-ed in responders of both genotypes who had moderate and severe steatosis.CONCLUSION:Increased serum leptin before treat-ment may predict non-SVR,especially in HCV geno-type-1 infected patients,whereas increased ghrelin may predict SVR in genotype-1.
引用
收藏
页码:5097 / 5104
页数:8
相关论文
共 50 条
  • [41] Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection
    Perumalswami, P
    Kleiner, DE
    Lutchman, G
    Heller, T
    Borg, B
    Park, Y
    Liang, TJ
    Hoofnagle, JH
    Ghany, MG
    HEPATOLOGY, 2006, 43 (04) : 780 - 787
  • [42] Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients
    Cholet, F
    Nousbaum, JB
    Richecceur, M
    Oger, E
    Cauvin, JM
    Lagarde, N
    Robaszkiewicz, M
    Gouérou, H
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 28 (03): : 272 - 278
  • [43] Steatosis associated with cirrhosis and fibrosis in chronic hepatitis C patients.
    Jamal, MM
    Wheeler, DE
    Quinn, PG
    Johnson, DE
    Chaturvedi, S
    Qualls, CR
    Arora, S
    GASTROENTEROLOGY, 1997, 112 (04) : A1293 - A1293
  • [44] Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C
    Antunez, I
    Aponte, N
    Fernandez, A
    Toro, DH
    Rodriguez-Perez, F
    GASTROENTEROLOGY, 2003, 124 (04) : A779 - A779
  • [45] Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
    Stan, Ionelia Sorina
    Biciusca, Viorel
    Durand, Patricia
    Petrescu, Ana-Maria
    Oancea, Dragos Mihai
    Ciuciulete, Alexandra Roxana
    Petrescu, Mihai
    Udristoiu, Ion
    Camen, Georgiana-Cristiana
    Balteanu, Mara Amalia
    Marginean, Cristina Maria
    Danoiu, Suzana
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2021, 62 (03): : 765 - 775
  • [46] Liver steatosis and response to interferon alpha in patients with chronic hepatitis C
    Kowdley, KV
    Dwight, MM
    Larson, AM
    Russo, J
    Katon, WJ
    HEPATOLOGY, 1998, 28 (04) : 569A - 569A
  • [47] Quantitative assessment of fibrosis and steatosis in patients with chronic hepatitis C.
    Zaitoun, AM
    Awad, S
    Ukabam, S
    Mokadissi, S
    Al Mardini, H
    HEPATOLOGY, 1998, 28 (04) : 643A - 643A
  • [48] Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
    Rocha, Chiara
    Doyle, Erin H.
    Bowman, Chip A.
    Fiel, M-Isabel
    Stueck, Ashley E.
    Goossens, Nicolas
    Bichoupan, Kian
    Crismale, James F.
    Makkar, Jasnit
    Lewis, Sara
    Perumalswami, Ponni V.
    Schiano, Thomas D.
    Hoshida, Yujin
    Schwartz, Myron
    Branch, Andrea D.
    Patel, Neal
    CANCER MEDICINE, 2023, 12 (09): : 10175 - 10186
  • [49] Prevalence and predictors of steatosis in patients with chronic hepatitis C (HCV) infection
    Nachnani, Jagdish S.
    Laya, Alexandra
    Sadeddin, Esmat
    Smith, Owen J.
    Alba, Laura M.
    Clarkston, Wendell K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S223 - S223
  • [50] Clinical implication of hepatic steatosis in patients with chronic hepatitis C.
    Hu, KQ
    Esrailian, E
    Runyon, B
    Thompson, K
    Chase, R
    Abdelhalim, F
    Hillebrand, D
    Tyler, D
    HEPATOLOGY, 2001, 34 (04) : 220A - 220A